Literature DB >> 14670077

Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1.

Ishtiaq Qadri1, Mieko Iwahashi, Juan M Capasso, Matthew W Hopken, Sonia Flores, Jerome Schaack, Francis R Simon.   

Abstract

Activation of cellular kinases and transcription factors mediates the early phase of the cellular response to chemically or biologically induced stress. In the present study we investigated the oxidant/antioxidant balance in Huh-7 cells expressing the HCV (hepatitis C virus) subgenomic replicon, and observed a 5-fold increase in oxidative stress during HCV replication. We used MnSOD (manganese-superoxide dismutase) as an indicator of the cellular antioxidant response, and found that its activity, protein levels and promoter activity were significantly increased, whereas Cu/ZnSOD was not affected. The oxidative stress-induced protein kinases p38 MAPK (mitogen-activated protein kinase) and JNK (c-Jun N-terminal kinase) were activated in the HCV repliconcontaining cells and in Huh-7 cells transduced with Ad-NS5A [a recombinant adenovirus encoding NS5A (non-structural protein 5A)], coupled with a 4-5-fold increase in AP-1 (activator protein-1) DNA binding. Ava.1 cells, which encode a replication-defective HCV replicon, showed no significant changes in MnSOD, p38 MAPK or JNK activity. The AP-1 inhibitors dithiothreitol and N -acetylcysteine, as well as a dominant negative AP-1 mutant, significantly reduced AP-1 activation, demonstrating that this activation is oxidative stress-related. Exogenous NS5A had no effect on AP-1 activation in vitro, suggesting that NS5A acts at the upstream targets of AP-1 involving p38 MAPK and JNK signalling cascades. AP-1-dependent gene expression was increased in HCV subgenomic replicon-expressing Huh-7 cells. MnSOD activation was blocked by inhibitors of JNK (JNKI1) and p38 MAPK (SB203580), but not by an ERK (extracellular-signal-regulated kinase) inhibitor (U0126), in HCV-replicating and Ad-NS5A-transduced cells. Our results demonstrate that cellular responses to oxidative stress in HCV subgenomic replicon-expressing and Ad-NS5A-transduced cells are regulated by two distinct signalling pathways involving p38 MAPK and JNK via AP-1 that is linked to increased oxidative stress and therefore to an increased antioxidant MnSOD response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670077      PMCID: PMC1224028          DOI: 10.1042/BJ20031587

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

1.  HIV Tat activates c-Jun amino-terminal kinase through an oxidant-dependent mechanism.

Authors:  Y Gu; R F Wu; Y C Xu; S C Flores; L S Terada
Journal:  Virology       Date:  2001-07-20       Impact factor: 3.616

2.  Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP.

Authors:  A K Ghosh; M Majumder; R Steele; P Yaciuk; J Chrivia; R Ray; R B Ray
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Dominant-negative TAK1 induces c-Myc and G(0) exit in liver.

Authors:  C A Bradham; E Hatano; D A Brenner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-11       Impact factor: 4.052

4.  Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection.

Authors:  F Farinati; R Cardin; P Degan; N De Maria; R A Floyd; D H Van Thiel; R Naccarato
Journal:  Free Radic Biol Med       Date:  1999-12       Impact factor: 7.376

5.  Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage.

Authors:  L De Franceschi; G Fattovich; F Turrini; K Ayi; C Brugnara; F Manzato; F Noventa; A M Stanzial; P Solero; R Corrocher
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

6.  Adenovirus-mediated wild-type-p53-gene expression sensitizes TNF-resistant tumor cells to TNF-induced cytotoxicity by altering the cellular redox state.

Authors:  V A Shatrov; M Ameyar; C Bouquet; Z Cai; R Stancou; H Haddada; S Chouaib
Journal:  Int J Cancer       Date:  2000-01-01       Impact factor: 7.396

7.  p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity.

Authors:  C E Helt; R C Rancourt; R J Staversky; M A O'Reilly
Journal:  Toxicol Sci       Date:  2001-10       Impact factor: 4.849

8.  Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.

Authors:  Y Zhao; Y Xue; T D Oberley; K K Kiningham; S M Lin; H C Yen; H Majima; J Hines; D St Clair
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

9.  Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

Authors:  N Kato; H Yoshida; S K Ono-Nita; J Kato; T Goto; M Otsuka; K Lan; K Matsushima; Y Shiratori; M Omata
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

10.  Hydrogen peroxide-induced liver cell necrosis is dependent on AP-1 activation.

Authors:  Y Xu; C Bradham; D A Brenner; M J Czaja
Journal:  Am J Physiol       Date:  1997-10
View more
  55 in total

1.  Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines.

Authors:  Bochra Gargouri; Jos Van Pelt; Abd El Fatteh El Feki; Hammadi Attia; Saloua Lassoued
Journal:  Mol Cell Biochem       Date:  2008-12-11       Impact factor: 3.396

2.  Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.

Authors:  Lance D Presser; Steven McRae; Gulam Waris
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

3.  Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma.

Authors:  Nobuyoshi Fukushima; Ryoko Kuromatsu; Jun Akiba; Eiji Ando; Akio Takata; Shuji Sumie; Masahito Nakano; Toru Nakamura; Akihiko Kawahara; Takuji Torimura; Osamu Nakashima; Koji Okuda; Hirohisa Yano; Masayoshi Kage; Masamichi Kojiro; Michio Sata
Journal:  Exp Ther Med       Date:  2010-07-21       Impact factor: 2.447

4.  Brain-derived neurotrophic factor increases expression of MnSOD in human circulating angiogenic cells.

Authors:  Tongrong He; Zvonimir S Katusic
Journal:  Microvasc Res       Date:  2012-01-09       Impact factor: 3.514

5.  Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.

Authors:  Xiaoning Si; Honglin Luo; Andrew Morgan; Jingchun Zhang; Jerry Wong; Ji Yuan; Mitra Esfandiarei; Guang Gao; Caroline Cheung; Bruce M McManus
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 6.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

7.  Modulation of mitogen-activated protein kinase-activated protein kinase 3 by hepatitis C virus core protein.

Authors:  Huong T T Ngo; Long V Pham; Jong-Wook Kim; Yun-Sook Lim; Soon B Hwang
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Role of free radicals in liver diseases.

Authors:  Pablo Muriel
Journal:  Hepatol Int       Date:  2009-11-26       Impact factor: 6.047

9.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

10.  HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice.

Authors:  Michael A Joyce; Kathie-Anne Walters; Sue-Ellen Lamb; Mathew M Yeh; Lin-Fu Zhu; Norman Kneteman; Jason S Doyle; Michael G Katze; D Lorne Tyrrell
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.